Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis Weitere Informationen
Potenzial von Escherichia coli Nissle 1917 in der Behandlung des septischen Schocks Weitere Informationen
Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Weitere Informationen